Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

C3 levels and acute outcomes in Shiga toxin-related hemolytic uremic syndrome.

Balestracci A, Meni Bataglia L, Toledo I, Beaudoin L, Alvarado C.

Pediatr Nephrol. 2019 Sep 2. doi: 10.1007/s00467-019-04334-3. [Epub ahead of print]

PMID:
31475299
2.

Author Correction: Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.

Rouxel O, DaSilva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A.

Nat Immunol. 2018 Sep;19(9):1035. doi: 10.1038/s41590-017-0023-9.

PMID:
29880894
3.

Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver.

Hegde P, Weiss E, Paradis V, Wan J, Mabire M, Sukriti S, Rautou PE, Albuquerque M, Picq O, Gupta AC, Ferrere G, Gilgenkrantz H, Kiaf B, Toubal A, Beaudoin L, Lettéron P, Moreau R, Lehuen A, Lotersztajn S.

Nat Commun. 2018 Jun 1;9(1):2146. doi: 10.1038/s41467-018-04450-y.

4.

Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.

Rouxel O, Da Silva J, Beaudoin L, Nel I, Tard C, Cagninacci L, Kiaf B, Oshima M, Diedisheim M, Salou M, Corbett A, Rossjohn J, McCluskey J, Scharfmann R, Battaglia M, Polak M, Lantz O, Beltrand J, Lehuen A.

Nat Immunol. 2017 Dec;18(12):1321-1331. doi: 10.1038/ni.3854. Epub 2017 Oct 9. Erratum in: Nat Immunol. 2018 Jun 7;:.

5.

Tools to Perform Local Dense 3D Reconstruction of Shallow Water Seabed.

Avanthey L, Beaudoin L, Gademer A, Roux M.

Sensors (Basel). 2016 May 17;16(5). pii: E712. doi: 10.3390/s16050712.

6.

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients.

Magalhaes I, Pingris K, Poitou C, Bessoles S, Venteclef N, Kiaf B, Beaudoin L, Da Silva J, Allatif O, Rossjohn J, Kjer-Nielsen L, McCluskey J, Ledoux S, Genser L, Torcivia A, Soudais C, Lantz O, Boitard C, Aron-Wisnewsky J, Larger E, Clément K, Lehuen A.

J Clin Invest. 2015 Apr;125(4):1752-62. doi: 10.1172/JCI78941. Epub 2015 Mar 9.

7.

Invariant NKT cells regulate the CD8 T cell response during Theiler's virus infection.

Mars LT, Mas M, Beaudoin L, Bauer J, Leite-de-Moraes M, Lehuen A, Bureau JF, Liblau RS.

PLoS One. 2014 Jan 30;9(1):e87717. doi: 10.1371/journal.pone.0087717. eCollection 2014.

8.

Plasmacytoid dendritic cells license regulatory T cells, upon iNKT-cell stimulation, to prevent autoimmune diabetes.

Beaudoin L, Diana J, Ghazarian L, Simoni Y, Boitard C, Lehuen A.

Eur J Immunol. 2014 May;44(5):1454-66. doi: 10.1002/eji.201343910. Epub 2014 Feb 27.

9.

[Regulatory role of NKT cells in the prevention of type 1 diabetes].

Ghazarian L, Simoni Y, Pingris K, Beaudoin L, Lehuen A.

Med Sci (Paris). 2013 Aug-Sep;29(8-9):722-8. doi: 10.1051/medsci/2013298010. Epub 2013 Sep 5. Review. French.

10.

Secretory IgA induces tolerogenic dendritic cells through SIGNR1 dampening autoimmunity in mice.

Diana J, Moura IC, Vaugier C, Gestin A, Tissandie E, Beaudoin L, Corthésy B, Hocini H, Lehuen A, Monteiro RC.

J Immunol. 2013 Sep 1;191(5):2335-43. doi: 10.4049/jimmunol.1300864. Epub 2013 Aug 7.

11.

Protection against type 1 diabetes upon Coxsackievirus B4 infection and iNKT-cell stimulation: role of suppressive macrophages.

Ghazarian L, Diana J, Beaudoin L, Larsson PG, Puri RK, van Rooijen N, Flodström-Tullberg M, Lehuen A.

Diabetes. 2013 Nov;62(11):3785-96. doi: 10.2337/db12-0958. Epub 2013 Jul 26.

12.

Mast cell chymase protects against renal fibrosis in murine unilateral ureteral obstruction.

Beghdadi W, Madjene LC, Claver J, Pejler G, Beaudoin L, Lehuen A, Daugas E, Blank U.

Kidney Int. 2013 Aug;84(2):317-26. doi: 10.1038/ki.2013.98. Epub 2013 Mar 20.

13.

Functional education of invariant NKT cells by dendritic cell tuning of SHP-1.

Napolitano A, Pittoni P, Beaudoin L, Lehuen A, Voehringer D, MacDonald HR, Dellabona P, Casorati G.

J Immunol. 2013 Apr 1;190(7):3299-308. doi: 10.4049/jimmunol.1203466. Epub 2013 Feb 20.

14.

Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes.

Diana J, Simoni Y, Furio L, Beaudoin L, Agerberth B, Barrat F, Lehuen A.

Nat Med. 2013 Jan;19(1):65-73. doi: 10.1038/nm.3042. Epub 2012 Dec 16.

PMID:
23242473
15.

Therapeutic manipulation of natural killer (NK) T cells in autoimmunity: are we close to reality?

Simoni Y, Diana J, Ghazarian L, Beaudoin L, Lehuen A.

Clin Exp Immunol. 2013 Jan;171(1):8-19. doi: 10.1111/j.1365-2249.2012.04625.x. Review.

16.

Prevention or acceleration of type 1 diabetes by viruses.

Ghazarian L, Diana J, Simoni Y, Beaudoin L, Lehuen A.

Cell Mol Life Sci. 2013 Jan;70(2):239-55. doi: 10.1007/s00018-012-1042-1. Epub 2012 Jul 6. Review. Erratum in: Cell Mol Life Sci. 2013 Jan;70(2):257.

PMID:
22766971
17.

NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes.

Simoni Y, Gautron AS, Beaudoin L, Bui LC, Michel ML, Coumoul X, Eberl G, Leite-de-Moraes M, Lehuen A.

Eur J Immunol. 2011 Dec;41(12):3574-85. doi: 10.1002/eji.201141751. Epub 2011 Nov 10.

18.

Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.

Diana J, Brezar V, Beaudoin L, Dalod M, Mellor A, Tafuri A, von Herrath M, Boitard C, Mallone R, Lehuen A.

J Exp Med. 2011 Apr 11;208(4):729-45. doi: 10.1084/jem.20101692. Epub 2011 Mar 28.

19.

NKT and tolerance.

Diana J, Beaudoin L, Gautron AS, Lehuen A.

Methods Mol Biol. 2011;677:193-206. doi: 10.1007/978-1-60761-869-0_14.

PMID:
20941612
20.

Invariant NKT cells in adrenoleukodystrophy patients and mice.

Gautron AS, Giquel B, Beaudoin L, Autrusseau E, Speak A, Platt F, Kemp S, Pujol A, Aubourg P, Lehuen A.

J Neuroimmunol. 2010 Dec 15;229(1-2):204-11. doi: 10.1016/j.jneuroim.2010.09.003.

PMID:
20920830
21.

NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner.

Diana J, Griseri T, Lagaye S, Beaudoin L, Autrusseau E, Gautron AS, Tomkiewicz C, Herbelin A, Barouki R, von Herrath M, Dalod M, Lehuen A.

Immunity. 2009 Feb 20;30(2):289-99. doi: 10.1016/j.immuni.2008.12.017. Epub 2009 Feb 12.

22.

Invariant NKT cells regulate experimental autoimmune encephalomyelitis and infiltrate the central nervous system in a CD1d-independent manner.

Mars LT, Gautron AS, Novak J, Beaudoin L, Diana J, Liblau RS, Lehuen A.

J Immunol. 2008 Aug 15;181(4):2321-9.

23.

Regulation of type 1 diabetes by NKT cells.

Novak J, Griseri T, Beaudoin L, Lehuen A.

Int Rev Immunol. 2007 Jan-Apr;26(1-2):49-72. Review.

PMID:
17454264
24.

Fc alpha receptor I activation induces leukocyte recruitment and promotes aggravation of glomerulonephritis through the FcR gamma adaptor.

Kanamaru Y, Arcos-Fajardo M, Moura IC, Tsuge T, Cohen H, Essig M, Vrtovsnik F, Loirat C, Peuchmaur M, Beaudoin L, Launay P, Lehuen A, Blank U, Monteiro RC.

Eur J Immunol. 2007 Apr;37(4):1116-28.

25.

Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression.

Novak J, Beaudoin L, Park S, Griseri T, Teyton L, Bendelac A, Lehuen A.

J Immunol. 2007 Feb 1;178(3):1332-40.

26.

Invariant NKT cells exacerbate type 1 diabetes induced by CD8 T cells.

Griseri T, Beaudoin L, Novak J, Mars LT, Lepault F, Liblau R, Lehuen A.

J Immunol. 2005 Aug 15;175(4):2091-101.

27.

Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes.

Wei DG, Lee H, Park SH, Beaudoin L, Teyton L, Lehuen A, Bendelac A.

J Exp Med. 2005 Jul 18;202(2):239-48.

28.

Inhibition of T cell differentiation into effectors by NKT cells requires cell contacts.

Novak J, Beaudoin L, Griseri T, Lehuen A.

J Immunol. 2005 Feb 15;174(4):1954-61.

29.

Randomized trial of paroxetine in end-stage COPD.

Lacasse Y, Beaudoin L, Rousseau L, Maltais F.

Monaldi Arch Chest Dis. 2004 Jul-Sep;61(3):140-7.

PMID:
15679006
30.

Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.

Ferlin WG, Mougneau E, Hugues S, Appel H, Jang MH, Cazareth J, Beaudoin L, Schricke C, Lehuen A, Wucherpfennig KW, Glaichenhaus N.

Eur J Immunol. 2004 Oct;34(10):2656-63.

31.

Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.

Stenström M, Sköld M, Ericsson A, Beaudoin L, Sidobre S, Kronenberg M, Lehuen A, Cardell S.

Eur J Immunol. 2004 Jan;34(1):56-65.

32.

Hassles: their importance to nurses' quality of work life.

Beaudoin LE, Edgar L.

Nurs Econ. 2003 May-Jun;21(3):106-13. No abstract available.

PMID:
12847983
33.
34.

Phenotypic and functional differences between NKT cells colonizing splanchnic and peripheral lymph nodes.

Laloux V, Beaudoin L, Ronet C, Lehuen A.

J Immunol. 2002 Apr 1;168(7):3251-8.

35.

Tolerance to islet antigens and prevention from diabetes induced by limited apoptosis of pancreatic beta cells.

Hugues S, Mougneau E, Ferlin W, Jeske D, Hofman P, Homann D, Beaudoin L, Schrike C, Von Herrath M, Lehuen A, Glaichenhaus N.

Immunity. 2002 Feb;16(2):169-81.

37.

[The ODEC (Organization for Development and Community Networks) and mental health: from networking to opening in the local community].

Beaudoin L, Duguay P, Fréchette L.

Can J Commun Ment Health. 1999 Autumn;18(2):73-86. French.

PMID:
10947640
38.

Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.

Launay P, Grossetête B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC.

J Exp Med. 2000 Jun 5;191(11):1999-2009. Erratum in: J Exp Med 2000 Jul 17;192(2):following 309.

39.

Acute systematic and variable postural adaptations induced by an orthopaedic shoe lift in control subjects.

Beaudoin L, Zabjek KF, Leroux MA, Coillard C, Rivard CH.

Eur Spine J. 1999;8(1):40-5.

40.

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

Lehuen A, Lantz O, Beaudoin L, Laloux V, Carnaud C, Bendelac A, Bach JF, Monteiro RC.

J Exp Med. 1998 Nov 16;188(10):1831-9.

41.

[Mental health. How to prevent burnout?].

Beaudoin L, Fortin B.

Infirm Que. 1998 Jul-Aug;5(6):40. French. No abstract available.

PMID:
9739243
42.

Intermittent rewards raise self-stimulation thresholds.

Fouriezos G, Emdin K, Beaudoin L.

Behav Brain Res. 1996 Jan;74(1-2):57-64.

PMID:
8851915
43.

T cell activation through Thy-1 is associated with the expression of a surface protein (p100) on a subset of CD4 cells.

Lehuen A, Beaudoin L, Bernard M, Kearney JF, Bach JF, Monteiro RC.

Int Immunol. 1995 Apr;7(4):607-16.

PMID:
7547688
44.

Localization of CS and non-CS antigens in the sporogonic stages of Plasmodium yoelii.

Aikawa M, Atkinson CT, Beaudoin LM, Sedegah M, Charoenvit Y, Beaudoin R.

Bull World Health Organ. 1990;68 Suppl:165-71.

45.

Freeze-fracture studies on the sporoblast and sporozoite development in the early oocyst.

Meszoely CA, Erbe EF, Beaudoin LM, Beaudoin RL.

Am J Trop Med Hyg. 1989 Nov;41(5):499-503.

PMID:
2683819
46.
47.

[The treatment of localized cancer of the prostate using radioactive iodine implants].

Fradet Y, Laverdière J, Beaudoin L.

Union Med Can. 1985 Sep;114(9):737-9. French. No abstract available.

PMID:
4060345
48.

[Selective celio-mesenteric arteriography in diagnosis and treatment of hepatic abscess].

Duranceau A, Cantin J, Beaudoin L, Roy P, Fontaine A, Fauteux J.

Union Med Can. 1971 Nov;100(11):2182-4. French. No abstract available.

PMID:
5150705
49.

[Microbial abscess of the liver. Apropos of 16 further cases].

Dandurand B, Saint-Martin M, Beaudoin L.

Union Med Can. 1969 Jan;98(1):55-62. French. No abstract available.

PMID:
4973877
50.

[Detection of bone metastases by an isotope method].

Thibault M, Langelier R, Beaudoin L.

Laval Med. 1966 Dec;37(10):1051-5. French. No abstract available.

PMID:
5989236

Supplemental Content

Loading ...
Support Center